Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial. (2023)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12882-023-03157-7

PubMed Identifier: 37118685

Publication URI: http://europepmc.org/abstract/MED/37118685

Type: Journal Article/Review

Volume: 24

Parent Publication: BMC nephrology

Issue: 1

ISSN: 1471-2369